Ambroxol Presentation
-
Upload
wahid-rezwan -
Category
Health & Medicine
-
view
716 -
download
18
description
Transcript of Ambroxol Presentation
Presentationon
WinkofAmbroxol Hydrocloride BP
Presented byMd. Wahid RezwanExecutive, PMDChemist Laboratories Ltd.Cell: 880001716356956E-mail: [email protected]
Executive SummaryExecutive Summary
Brand Name : Winkof
Generic Name : Ambroxol Hydrochloride BP
Therapeutic Class : Mucoactive Agent
Dosage Form : Syrup
Strength : 100ml
Flavor : Banana
Winkof Carton
Winkof Sticker
General Information
Winkof (Ambroxol Hydrochloride) is a Mucoactive
agent used in the treatment of
respiratory diseases associated with
excessive mucus.
Mucus
Mucus is a slippery secretion produced by mucus membranes. It is a normal protective layering around the airway, eye and urinary tract.
Mucus is an adhesive gel produced in the airway by submucosal glands
and goblet cells and
is principally water.
Mucous cells on the stomach lining
PhlegmPhlegm
Phlegm is more related to disease than is mucus. Phlegm is a secretion in the airway during disease and inflammation. Phlegm usually contains mucus with bacteria, dust.
Once phlegm has been expectorated by a cough
it becomes sputum.
CiliaCilia
Cilia are short, hair-like, rhythmically beating
organelles on the surface of certain cells.
It moves or expels fluids, abnormal
phlegm , dust particles and microbes
by their conveyor belt like action.
CiliaCilia
CiliaCilia
CoughCough
A cough is a sudden and often repetitively
occurring reflex which helps to clear the large
breathing passages from secretions, irritants,
foreign particles and microbes.
Classification:1. Non Productive cough ( Dry Cough )
2. Productive cough ( Wet cough )
WinkofAmbroxol Hydrochlorid BP
Drugs of Respiratory SystemDrugs of Respiratory System
Product Information
Winkof is a preparation of Ambroxol Hydrochloride.
It possesses both Expectorant & Mucolytic effects.
It increases bronchial secretion and decreases viscosity to
make coughs more productive.
It dilutes the thick mucus in the respiration track and
facilitates excretion of it.
IndicationsIndications
• Acute I Chronic Bronchitis Gi Kvi‡b m„ó k¦vmZ‡š¿i Cough `~i K‡i|
• Laryngitis, Pharyngitis, Sinusitis BZ¨vw` †iv‡Mi Kvi‡b m„ó Cough, ey‡K e¨v_v I Mjvi e¨v_v `~i K‡i|
• Asthmatic Bronchitis Gi Kvi‡b m„ó njy` ev meyR Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i|
• Bronchiectasis Gi Kvi‡b m„ó `~M©Ühy³ njy` ev meyR Cough `~i K‡i|
• Chronic Pneumonia Gi Kvi‡b m„ó Nb Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i|
Mechanism of ActionMechanism of Action
Winkof
Expectorant Mucolytic
Increases the bronchial secretion
Breakdown of Acid Mucopolysaccharide Fiber
Lubricate the irritated Respiratory Tract
Thinner & Watery mucus
Increased mucus flow by cilia through coughing
DosageDosage
Adult (Above 10years) : 10ml ( 2 Spoonful ) 2-3times
Child :
(5-10 Years) : 5ml (1 Spoonful) 2-3times
(2-5 Years) : 2.5ml (1/2 Spoonful) 2-3times
(1-2 Years) : 1.5ml 2times
(6-12 Months) : 1ml 2times
(0-6 months) : 0.5ml (2 times daily)
Current Market situation :
Market Size
Cr. TK. Growth % Market Share
COUGH & COLD PREPARATIONS 115.51 19.56 13.91 EXPECTORANTS 68.78 13.55 59.54 AMBROXOL 33.91 12.93 49.30
Brand Name Company
AMBROX SQUARE 15.95 12.82 47.04
BOXOL OPSONIN 4.32 63.79 12.77
AMBOLYT INCEPTA 4.23 35.71 12.48
LYTEX IBN SINA 1.62 9.53 4.79
MYROX ACI 1.04 -31.14 3.09
SWOT Analysis
Strengths Weaknesses
1. We have more than 700 Field Force.
2. We’ve Dynamic Leaders like you3. We have 555 Doctors (MBBS&
above)4. We have 593 Doctors (Below
MBBS)
1. Late entry
2. Poor product knowledge
3. No list of Specialized Doctors
4. Lack of monitoring.
Opportunities Threats
1. High growth rate market.
2. Better than Cough Suppressants
3. We’ve got Winter Season
1. Aggressive competitor activity
Qualitative :Qualitative :
Make Winkof as an Established
Brand by creating complete Brand
Awareness.
To hold a Good Position in the
market.
Proper use of Promo Materials.
QuantitativeQuantitative : :
Brand Sales/Month (Unit)Sales/Month (Tentative
Value)
Winkof 30,000 7.5 Lac
Monthly Sales target :
Rx Analysis
Category Number of FF Exp. Rx / Day Est. Rx/ MonthTotal Tentative Value/ Month
A 100 3 7,200
6.72 LacB 150 2 7,200
C 200 1 4,800
Total 450 1.78 19,200
If 30% System loss = 10 Lac
If 100% of Trader’s sales = 13.5 Lac
Target Doctors
• Chest Specialists• Medicine Specialists• Child Specialists• GPs• RMPs/PCs
As well as Chemist Shop
MonitoringMonitoring Activities Activities
Ensure 100% utilization of Logistics and Samples.
Gifts must be distributed through Joint Call (By Leader + Promoter).
Strict monitoring and emphasizing on poor performance Area.
Maintain Daily Communication with Team Leader.
THANKSTHANKS